Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Belzutifan in Recurrent Ovarian Clear Cell Adenocarcinoma: NCT06677190 Clinical Landscape Report 2026
15 October 2026
NCT06677190 clinical landscape for Recurrent Ovarian Clear Cell Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
ASP-1893 in Locally Advanced Malignant Solid Neoplasm: NCT06681870 Clinical Landscape Report 2026
15 October 2026
NCT06681870 clinical landscape for Locally Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development w…
![[18F]RCCB6 in Renal Cell Carcinoma: NCT06680089 Clinical Landscape Report 2026](https://synapse-static-patsnap-com.libproxy1.nus.edu.sg/strapi-static/Blog_cover_14_36b6ffee12.jpg)
9 min read
[18F]RCCB6 in Renal Cell Carcinoma: NCT06680089 Clinical Landscape Report 2026
15 October 2026
NCT06680089 clinical landscape for Renal Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Celecoxib in Melanoma, Cutaneous Malignant: ACTRN12624001353583 Clinical Landscape Report 2026
15 October 2026
ACTRN12624001353583 clinical landscape for Melanoma, Cutaneous Malignant: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Tremelimumab in Endometrial Carcinoma: NCT06680739 Clinical Landscape Report 2026
15 October 2026
NCT06680739 clinical landscape for Endometrial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ivonescimab in germ cell cancers: NCT06683846 Clinical Landscape Report 2026
15 October 2026
NCT06683846 clinical landscape for germ cell cancers: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Albumin-Bound Paclitaxel in Extramammary Paget Disease: NCT06684327 Clinical Landscape Report 2026
15 October 2026
NCT06684327 clinical landscape for Extramammary Paget Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cyclophosphamide in Diffuse Large B-Cell Lymphoma: NCT06683885 Clinical Landscape Report 2026
15 October 2026
NCT06683885 clinical landscape for Diffuse Large B-Cell Lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ipilimumab in Metastatic melanoma: NCT06683755 Clinical Landscape Report 2026
15 October 2026
NCT06683755 clinical landscape for Metastatic melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
A2B-395 in Adenocarcinoma of large intestine: NCT06682793 Clinical Landscape Report 2026
15 October 2026
NCT06682793 clinical landscape for Adenocarcinoma of large intestine: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Carmustine in Diffuse Large B-Cell Lymphoma: NCT06687772 Clinical Landscape Report 2026
15 October 2026
NCT06687772 clinical landscape for Diffuse Large B-Cell Lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Toripalimab in Triple Negative Breast Cancer: NCT06682195 Clinical Landscape Report 2026
15 October 2026
NCT06682195 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.